Latest Breaking News On - Pharma royalties - Page 1 : comparemela.com

Fitch Ratings has affirmed Royalty Pharma plc s Long-Term Issuer Default Rating at BBB- and the BBB- debt ratings on its existing senior unsecured notes. The Rating Outlook is Stable. Fitch s.

Fitch ratingsDevelopment stage investmentsRp holdingLong term issuer default ratingRating outlookPharma royaltiesCash flowsStage investmentsProduct safetyLiability issuesInflation reduction actHuman resourcesKey assumptions within our rating casePositive ratingNegative ratingMaturities manageable